NEW YORK (GenomeWeb News) – The National Institutes of Health sees metabolomics as a discipline with great potential for the study and treatment of disease, and said today that it plans to invest as much as $51.4 million over five years to bolster this new field through the NIH Common Fund.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.